43.20
0.23%
+0.075
Precedente Chiudi:
$43.13
Aprire:
$43.71
Volume 24 ore:
4.40M
Capitalizzazione di mercato:
$20.59B
Reddito:
$3.67B
Utile/perdita netta:
$-802.14M
Rapporto P/E:
-19.82
EPS:
-2.18
Flusso di cassa netto:
$-115.14M
1 W Prestazione:
+6.61%
1M Prestazione:
-4.80%
6M Prestazione:
+62.27%
1 anno Prestazione:
+97.31%
DraftKings Inc. Stock (DKNG) Company Profile
Nome
DraftKings Inc.
Settore
Industria
Telefono
617 986 6744
Indirizzo
222 Berkeley Street, 5th Floor, Boston, MA
DraftKings Inc. Stock (DKNG) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-02-13 | Reiterato | Oppenheimer | Outperform |
2024-02-13 | Reiterato | Piper Sandler | Overweight |
2024-01-19 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
2024-01-19 | Aggiornamento | Stifel | Hold → Buy |
2024-01-09 | Iniziato | BMO Capital Markets | Outperform |
2023-11-27 | Reiterato | Argus | Buy |
2023-10-24 | Aggiornamento | MoffettNathanson | Hold → Buy |
2023-09-26 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-08-09 | Aggiornamento | JP Morgan | Underweight → Neutral |
2023-08-08 | Aggiornamento | Truist | Hold → Buy |
2023-08-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-07-18 | Reiterato | ROTH MKM | Sell |
2023-07-17 | Reiterato | Jefferies | Buy |
2023-07-14 | Reiterato | Morgan Stanley | Overweight |
2023-07-12 | Aggiornamento | BofA Securities | Neutral → Buy |
2023-07-12 | Reiterato | The Benchmark Company | Buy |
2023-05-22 | Aggiornamento | UBS | Neutral → Buy |
2023-05-08 | Reiterato | ROTH MKM | Sell |
2023-05-05 | Reiterato | BTIG Research | Buy |
2023-05-05 | Reiterato | BofA Securities | Neutral |
2023-05-05 | Reiterato | Oppenheimer | Outperform |
2023-05-05 | Reiterato | The Benchmark Company | Buy |
2023-04-13 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
2023-03-07 | Aggiornamento | Argus | Hold → Buy |
2023-02-17 | Aggiornamento | BTIG Research | Neutral → Buy |
2023-02-09 | Downgrade | ROTH Capital | Neutral → Sell |
2023-02-09 | Downgrade | ROTH MKM | Neutral → Sell |
2023-01-24 | Iniziato | Stifel | Hold |
2022-12-12 | Downgrade | ROTH Capital | Buy → Neutral |
2022-11-28 | Downgrade | JP Morgan | Neutral → Underweight |
2022-11-18 | Iniziato | Piper Sandler | Overweight |
2022-10-12 | Iniziato | Redburn | Neutral |
2022-10-06 | Iniziato | Exane BNP Paribas | Underperform |
2022-08-17 | Aggiornamento | ROTH Capital | Neutral → Buy |
2022-06-29 | Iniziato | Barclays | Equal Weight |
2022-06-28 | Iniziato | JMP Securities | Mkt Outperform |
2022-06-23 | Ripresa | Morgan Stanley | Overweight |
2022-05-16 | Ripresa | Jefferies | Buy |
2022-03-07 | Downgrade | Argus | Buy → Hold |
2022-02-22 | Reiterato | BofA Securities | Neutral |
2022-02-22 | Reiterato | Canaccord Genuity | Buy |
2022-02-22 | Reiterato | Deutsche Bank | Hold |
2022-02-22 | Reiterato | Needham | Buy |
2022-02-22 | Reiterato | Oppenheimer | Outperform |
2022-02-22 | Aggiornamento | ROTH Capital | Sell → Neutral |
2022-02-22 | Reiterato | Truist | Hold |
2022-02-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-01-26 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2021-12-13 | Iniziato | MoffettNathanson | Neutral |
2021-11-08 | Reiterato | Deutsche Bank | Hold |
2021-11-08 | Reiterato | Oppenheimer | Outperform |
2021-11-08 | Reiterato | ROTH Capital | Sell |
2021-11-08 | Reiterato | Truist | Hold |
2021-11-02 | Ripresa | Morgan Stanley | Equal-Weight |
2021-10-27 | Iniziato | BTIG Research | Neutral |
2021-10-12 | Iniziato | ROTH Capital | Sell |
2021-10-11 | Iniziato | Citigroup | Buy |
2021-09-15 | Iniziato | Wells Fargo | Overweight |
2021-09-14 | Reiterato | Craig Hallum | Buy |
2021-08-09 | Reiterato | The Benchmark Company | Buy |
2021-05-12 | Aggiornamento | Berenberg | Sell → Hold |
2021-05-03 | Aggiornamento | Cowen | Market Perform → Outperform |
2021-04-30 | Iniziato | Guggenheim | Buy |
2021-04-27 | Iniziato | Needham | Buy |
2021-03-23 | Reiterato | Goldman | Buy |
2021-03-10 | Reiterato | The Benchmark Company | Buy |
2021-02-01 | Reiterato | The Benchmark Company | Buy |
2021-01-27 | Iniziato | Bernstein | Outperform |
2021-01-26 | Aggiornamento | Goldman | Neutral → Buy |
2021-01-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2021-01-19 | Iniziato | Berenberg | Sell |
2020-12-07 | Iniziato | JP Morgan | Neutral |
2020-11-24 | Iniziato | UBS | Neutral |
2020-11-20 | Iniziato | Piper Sandler | Overweight |
2020-10-12 | Iniziato | Credit Suisse | Outperform |
2020-10-12 | Iniziato | Deutsche Bank | Hold |
2020-10-08 | Iniziato | Cowen | Market Perform |
2020-10-01 | Iniziato | Needham | Buy |
2020-09-25 | Iniziato | Argus | Buy |
2020-09-24 | Iniziato | Macquarie | Outperform |
2020-09-15 | Reiterato | The Benchmark Company | Buy |
2020-09-14 | Iniziato | Wolfe Research | Peer Perform |
2020-09-09 | Iniziato | Evercore ISI | Outperform |
2020-09-08 | Iniziato | BofA Securities | Neutral |
2020-09-02 | Iniziato | Truist | Hold |
2020-08-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-08-17 | Reiterato | The Benchmark Company | Buy |
2020-07-31 | Iniziato | The Benchmark Company | Buy |
2020-07-01 | Iniziato | Stephens | Overweight |
2020-06-26 | Iniziato | Rosenblatt | Buy |
2020-06-22 | Iniziato | Jefferies | Buy |
Mostra tutto
DraftKings Inc. Borsa (DKNG) Ultime notizie
DraftKings (DKNG) to Report Q1 Earnings: What's in Store?
Zacks Investment Research
How to Play Norwegian Cruise (NCLH) Ahead of Q1 Earnings?
Zacks Investment Research
Got $1,000? 3 Stocks to Buy Now While They're On Sale
The Motley Fool
DraftKings (DKNG) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Zacks Investment Research
DraftKings Inc. (DKNG) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
Is DraftKings Stock Going to $60? 1 Wall Street Analyst Thinks So.
The Motley Fool
DraftKings Inc. Azioni (DKNG) Dati Finanziari
DraftKings Inc. (DKNG) Reddito 2024
DKNG ha riportato un ricavo (TTM) di $3.67 miliardi per il trimestre terminato il 2023-12-31, un +63.60% salita anno su anno.
DraftKings Inc. (DKNG) Reddito netto 2024
DKNG l'utile netto (TTM) è stato di -$802.14 milioni per il trimestre terminato il 2023-12-31, un +41.79% aumento anno su anno.
DraftKings Inc. (DKNG) Flusso di cassa 2024
DKNG ha registrato un flusso di cassa disponibile (TTM) di -$115.14 milioni per il trimestre conclusosi con 2023-12-31, un +84.21% aumento anno su anno.
DraftKings Inc. (DKNG) Utile per azione 2024
L'utile per azione (TTM) di DKNG è stato pari a -$1.75 per il trimestre terminato il 2023-12-31, un +44.79% crescita anno su anno.
DraftKings Inc. Azioni (DKNG) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Robins Jason | See Remarks |
Feb 21 '24 |
Sale |
40.89 |
200,000 |
8,178,308 |
3,195,812 |
Dodge R Stanton | Chief Legal Officer |
Feb 08 '24 |
Option Exercise |
2.95 |
52,777 |
155,692 |
886,340 |
Dodge R Stanton | Chief Legal Officer |
Feb 08 '24 |
Sale |
43.06 |
686,101 |
29,543,509 |
200,239 |
Robins Jason | See Remarks |
Feb 08 '24 |
Sale |
43.06 |
450,000 |
19,377,000 |
3,373,637 |
Liberman Paul | See Remarks |
Jan 29 '24 |
Sale |
40.00 |
510,000 |
20,400,000 |
2,291,406 |
Dodge R Stanton | Chief Legal Officer |
Jan 22 '24 |
Option Exercise |
2.95 |
52,777 |
155,692 |
883,233 |
Robins Jason | See Remarks |
Jan 22 '24 |
Sale |
37.82 |
200,000 |
7,564,455 |
3,815,698 |
Dodge R Stanton | Chief Legal Officer |
Jan 22 '24 |
Sale |
37.82 |
52,777 |
1,996,026 |
830,456 |
Robins Jason | See Remarks |
Dec 20 '23 |
Sale |
35.30 |
244,821 |
8,642,181 |
4,015,698 |
Robins Jason | See Remarks |
Dec 19 '23 |
Sale |
35.65 |
238,629 |
8,507,208 |
3,760,519 |
Capitalizzazione:
|
Volume (24 ore):